Stocks · Healthcare · Medical - Care Facilities
U.S. Physical Therapy, Inc. USPH
$83.72 +1.36% Close, Oct 2, 2026 · NYSE · Market cap $1.27B
Next earnings report: Nov 4, 2026
Scroll or pinch to zoom, drag to move. Daily prices adjusted for splits. Markers: E = earnings (green beat, red miss), S = split, D = dividend.
Three things to know
- Diluted EPS over the last four quarters was $0.17, down 92.6% year over year.
- At 492.5× trailing earnings, the shares trade at the highest P/E of the company's past five years.
- Net debt is 3.6× EBITDA, a high level of leverage.
PromtFinance scores
Each score is a percentile within the Healthcare sector (0–100). Under each score: how the stock ranks in its sector on every component. As of Oct 5, 2026.
How fast revenue, earnings and cash flow are growing.
- Revenue growth (TTM, YoY)Top 36%
- EPS growth (TTM, YoY)Bottom 18%
- FCF growth (TTM, YoY)Bottom 46%
- Revenue growth, 3-year CAGRTop 45%
- Revenue growth accelerationTop 14%
Returns on capital, margins, earnings quality and balance-sheet strength.
- Return on invested capitalTop 23%
- Gross marginBottom 14%
- Operating marginTop 25%
- Accruals (lower is better)Top 47%
- Net debt / EBITDA (lower is better)Bottom 23%
- Interest coverTop 19%
How cheap the shares are relative to earnings, cash flow and their own history.
- Earnings yieldTop 30%
- Free-cash-flow yieldTop 18%
- EBITDA / enterprise valueTop 19%
- Sales / enterprise valueTop 26%
- P/E vs own 5-year history (lower is better)Bottom 3%
Strength and persistence of the price trend, including versus the S&P 500.
- 12-month return excluding last monthBottom 30%
- 6-month returnTop 45%
- 1-year return vs S&P 500Bottom 41%
- Distance from 52-week highTop 16%
- Trend checklist (0–4)Top 7%
Earnings surprises and analyst sentiment (estimate-revision history is being collected).
- Average EPS surprise, last 4 quartersBottom 32%
- Consecutive EPS beatsBottom 20%
- Share of analysts rating BuyTop 50%
- Upside to consensus price targetBottom 16%
Low volatility, shallow drawdowns, low market sensitivity and modest leverage.
- Volatility, 60 days (lower is better)Top 6%
- Maximum drawdown, 3 yearsTop 21%
- Beta vs S&P 500 (lower is better)Top 48%
- Net debt / EBITDA (lower is better)Bottom 23%
What changed
Latest four quarters versus the same period a year earlier (growth: versus one quarter earlier).
| Measure | Before | Now | |
|---|---|---|---|
| Revenue growth (YoY) | 9.1% | 17.1% | ↑ |
| EPS growth (YoY) | -77.1% | -92.6% | ↓ |
| Gross margin | 20.4% | 19.2% | ↓ |
| Operating margin | 11.1% | 10.8% | ↓ |
| FCF margin | 9.2% | 8.2% | ↓ |
Fundamental momentum
| Measure | Now (TTM) | Year / quarter before | Sector rank | |
|---|---|---|---|---|
| Revenue growth (TTM, YoY) | 17.1% | 9.1% | ↑ | Top 36% |
| EPS growth (TTM, YoY) | -92.6% | -77.1% | ↓ | Bottom 18% |
| Gross margin | 19.2% | 20.4% | ↓ | Bottom 14% |
| Operating margin | 10.8% | 11.1% | ↓ | Top 25% |
| Net margin | -0.8% | 4.8% | ↓ | — |
| Free-cash-flow margin | 8.2% | 9.2% | ↓ | — |
| Return on invested capital | 5.2% | — | Top 23% | |
| Revenue growth, 3-year CAGR | 12.2% | — | Top 45% |
Quality of earnings and balance sheet
- Accruals (net income − OCF) / assetsLower is better; high accruals can signal weaker earnings quality.
- -7.1%
- Stock-based compensation / revenueA cost to shareholders through dilution.
- 1.3%
- Receivables growth vs revenue growthReceivables growing much faster than sales can be a warning.
- -12.0 pp
- Net debt / EBITDABelow 1× is conservative; above 3× is high leverage.
- 3.60×
- Interest cover (operating income / interest)How many times operating profit covers interest.
- 7.8×
Shareholder returns
- Dividend yield (dividends paid, TTM)
- 2.16%
- Net buyback yield (TTM)
- 1.95%
- Shareholder yield
- 4.11%
- Share count change, 1 year
- -0.8%
- Share count change, 3-year CAGR
- +3.2%
Shareholder yield = dividends + net buybacks over the last four quarters, divided by market cap.
Based on the four quarters through Jun 30, 2026 (filed Aug 7, 2026).
Earnings and expectations
Earnings momentum
- Consecutive EPS beats
- 0
- Beats in the last 8 reports
- 3 of 8
- Average EPS surprise, last 4
- -6.4%
- Average 2-day reaction, last 8
- +0.5%
- Positive 20 days after report
- 4 of 8
Analysts
- Consensus price target
- $90.00
- Target vs current price
- +7.5%
- Analysts with a rating
- 13
- Share rating Buy or Strong Buy
- 77%
- Consensus rating
- Buy
How the stock reacted to recent reports
| Report date | EPS surprise | 2 days | 5 days | 20 days | 60 days |
|---|---|---|---|---|---|
| Aug 5, 2026 | -7.9% | +2.4% | +7.7% | +2.5% | — |
| May 6, 2026 | -16.4% | +2.7% | -15.2% | -13.8% | +10.2% |
| Feb 25, 2026 | +0.0% | -1.4% | +0.4% | -9.9% | -24.9% |
| Nov 5, 2025 | -1.5% | +1.2% | -14.5% | -13.4% | -3.9% |
| Aug 6, 2025 | +14.1% | +0.9% | +21.5% | +16.3% | +22.3% |
| May 7, 2025 | +4.3% | -0.9% | +7.9% | +4.5% | -2.2% |
| Feb 26, 2025 | -5.8% | -0.4% | -9.9% | -16.8% | -12.3% |
| Nov 5, 2024 | +1.5% | -0.3% | +14.3% | +19.6% | +6.5% |
Returns from the close before each report. Past reactions do not determine future ones.
Earnings history
| Report date | EPS | Estimate | Surprise | Revenue |
|---|---|---|---|---|
| Aug 5, 2026 | $0.75 | $0.81 | -7.9% | $214.1M |
| May 6, 2026 | $0.46 | $0.55 | -16.4% | $198.3M |
| Feb 25, 2026 | $0.67 | $0.67 | +0.0% | $202.7M |
| Nov 5, 2025 | $0.66 | $0.67 | -1.5% | $164.0M |
| Aug 6, 2025 | $0.81 | $0.71 | +14.1% | $164.2M |
| May 7, 2025 | $0.48 | $0.46 | +4.3% | $152.5M |
| Feb 26, 2025 | $0.65 | $0.69 | -5.8% | $180.4M |
| Nov 5, 2024 | $0.69 | $0.68 | +1.5% | $168.0M |
Valuation in context
| Multiple | Now | 5-year median | 5-year percentile | Sector rank (cheapness) |
|---|---|---|---|---|
| P/E (trailing) | 492.5× | 41.3× | 100th | Top 30% |
| P/E (forward) | 28.9× | — | — | — |
| EV / EBITDA | 16.3× | — | — | Top 19% |
| EV / Sales | 2.10× | — | — | Top 26% |
| Free-cash-flow yield | 5.03% | — | — | Top 18% |
| Earnings yield | 0.20% | — | — | Top 30% |
P/E over the past five years
Range 26.6× – 470.9× since Jun 30, 2021. Each point: price on the filing date divided by trailing-twelve-month EPS known then.
What moved the stock over the past year
- Price return, 1 year
- -2.7%
- Earnings per share growth (TTM)
- -92.6%
- Change in P/E multiple
- +1129.8%
Most of the move came from earnings growth.
Technical state
Trend checklist
- ✓ Price above 20-day average
- ✓ Price above 50-day average
- ✓ Price above 200-day average
- ✓ 50-day average above 200-day
- ✓ MACD histogram positive
Trend quality
- Days above the 50-day average
- 69
- Days above the 200-day average
- 42
- 50-day average slope (20 days)
- +5.5%
- 200-day average slope (20 days)
- +1.0%
- Distance from 50-day average
- +4.5%
- Distance from 200-day average
- +9.8%
- RSI (14)
- 57.3
- Relative volume
- 1.34×
Risk and drawdowns
- Volatility, 60 days (annualized)
- 26.4%
- Volatility vs own 5-year history
- 14th percentile · Low for this stock
- Beta vs S&P 500 (2 years, weekly)
- 1.07
- Correlation with S&P 500
- 0.42
- Current drawdown from 1-year high
- -10.1%
- Maximum drawdown, 3 years
- -47.7%
Largest declines in the past six years
| From peak | To low | Decline | Length | Recovery |
|---|---|---|---|---|
| Feb 24, 2021 | May 7, 2026 | -58.3% | 1306 days | Not yet recovered |
| Oct 8, 2020 | Oct 28, 2020 | -15.3% | 14 days | 6 days (Nov 5, 2020) |
| Jan 26, 2021 | Jan 29, 2021 | -10.1% | 3 days | 6 days (Feb 8, 2021) |
Declines of 10% or more from a closing high, measured on daily closes.
Financial statements
- Market cap
- $1.27B
- P/E (TTM)
- 492.5
- EPS, diluted (TTM)
- $0.17
- Revenue (TTM)
- $779.1M
- Dividend yield
- 2.19%
- 52-week range
- $58.19 – $93.50
| FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|
| Revenue | $495.0M | $553.1M | $604.8M | $671.3M | $781.0M |
| Gross profit | $117.2M | $112.0M | $121.5M | $123.9M | $157.3M |
| Operating income | $70.6M | $56.8M | $52.1M | $63.2M | $80.4M |
| Net income | $27.8M | $28.3M | $14.7M | $26.5M | $15.1M |
| EPS (diluted) | $4.49 | $3.34 | $1.28 | $1.84 | $1.42 |
| Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | Q1 2026 | Q2 2026 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $168.0M | $180.4M | $152.5M | $164.2M | $164.0M | $202.7M | $198.3M | $214.1M |
| Net income | $5.5M | $7.4M | $9.9M | $8.8M | $7.2M | -$10.5M | -$4.3M | $1.6M |
| EPS (diluted) | $0.39 | $0.52 | $0.80 | $0.58 | $0.48 | -$0.44 | -$0.12 | $0.25 |
| FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|
| Operating cash flow | $76.4M | $58.5M | $82.0M | $74.9M | $75.1M |
| Capital expenditure | -$8.2M | -$8.2M | -$9.3M | -$9.2M | -$14.1M |
| Free cash flow | $68.2M | $50.3M | $72.7M | $65.8M | $61.0M |
| Dividends paid | -$18.8M | -$21.3M | -$24.1M | -$26.5M | -$27.4M |
| Net share buybacks | $0 | $0 | $163.6M | $0 | -$5.6M |
Cash outflows are shown as negative numbers.
- Cash and short-term investments
- $24.9M
- Total assets
- $1.25B
- Total liabilities
- $482.2M
- Total debt
- $385.8M
- Net debt
- $360.9M
- Shareholders’ equity
- $448.7M
As of Jun 30, 2026 (filed Aug 7, 2026).
Dividends
| Ex-date | Amount | Paid |
|---|---|---|
| Aug 21, 2026 | $0.46 | Sep 11, 2026 |
| May 22, 2026 | $0.46 | Jun 12, 2026 |
| Mar 13, 2026 | $0.46 | Apr 10, 2026 |
| Nov 17, 2025 | $0.45 | Dec 12, 2025 |
| Aug 22, 2025 | $0.45 | Sep 12, 2025 |
| May 23, 2025 | $0.45 | Jun 13, 2025 |
| Mar 14, 2025 | $0.45 | Apr 11, 2025 |
| Nov 15, 2024 | $0.44 | Dec 6, 2024 |
Short interest
- Shares sold short
- 1,293,611
- Days to cover
- 8.12
- Change vs previous report
- +0.7%
FINRA short interest, settlement date Sep 15, 2026.
Stock splits
- Jun 29, 2001
- 3-for-2
- Jan 8, 2001
- 2-for-1